This content is machine translated Bone metastases in breast carcinoma Pain, fractures, and what to do about them Bone metastases in breast carcinoma are common. So-called bone-modifying agents (bisphosphonates, denosumab) are combined with system therapy. They significantly reduce “skeletal-related events.”
View Post 5 min This content is machine translated Sport during pregnancy Is physical activity dangerous? Just a few years ago, pregnant women were advised to avoid exercise during gestation. Even today, uncertainty sometimes prevails: Can sport lead to injuries or even premature abortion of the…
View Post 7 min This content is machine translated Perinatal health/teratogenicity. Cannabis in pregnancy Cannabis use has potentially harmful effects perinatally. However, the rate of abortions, congenital malformations, preterm births, or other complications is not increased. Chronic maternal cannabis abuse is associated with a…
View Post 6 min This content is machine translated Adjuvant chemotherapy in breast carcinoma Multitests for individual indication The use of the four multigene tests MammaPrint, Oncotype DX, EndoPredict and Prosigna may be useful in deciding on adjuvant chemotherapy. In which patients in particular should they be used?
View Post 5 min This content is machine translated Allergies in the genital area Careful anamnesis is crucial About half of balanoposthitides and vulvovaginitides are allergic. In addition to a careful anamnesis regarding hygiene habits and products used, sexual anamnesis is of great importance.
View Post 6 min This content is machine translated ESMO 2018 in Munich Quantum leap in ovarian cancer? The SOLO-1 trial was one of the “hot” topics at this year’s ESMO. A PFS improvement of 70% with good tolerance and efficacy not only in recurrences suggest a relevant…
View Post 1 min This content is machine translated Special report: maintenance therapy of relapsed ovarian cancer. Niraparib approved with individual starting doses In October 2018, the poly (ADP-ribose) polymerase (PARP) inhibitor niraparib (Zejula®) was approved for the maintenance treatment of relapsed ovarian cancer [1]. It can be used regardless of BRCA mutation…
View Post 6 min This content is machine translated DGHO in Vienna Prostate and breast cancer: the future belongs to combined therapies Treatment options are often limited in both prostate and breast carcinoma. The search for new effective drugs and combination therapies is therefore the primary goal of current studies.
View Post 8 min This content is machine translated Multiple sclerosis and pregnancy Recommendation status on childbearing and medication Multiple sclerosis (MS) does not adversely affect fertility, pregnancy, fetal development, or birth. Post partum, there is a 30% increased risk of relapse, although this depends on the relapse rate…
View Post 16 min This content is machine translated Pregnancy planning, monitoring, peri- and postpartum Epilepsy and childbearing Most pregnancies with epilepsy proceed without problems, but it is important to anticipate epilepsy-specific problems and to work on them together with the doctor and the patient within the framework…
View Post 6 min This content is machine translated Dangerous rarity Splenic artery aneurysm in women: Clinic, Diagnosis and Therapy Splenic artery aneurysm is a rare but dangerous condition with female predominance. It is poorly treatable, is usually asymptomatic, and often ruptures spontaneously.
